Seasonal affective disorder: What is a connection between Winter and depression? With the change in weather, most people also experience a change in their...
AstraZeneca said a late-stage trial confirmed the benefit of breast cancer drug Enhertu in patients with an innovative form of the disease who formerly treated with another therapy. AstraZeneca protected partial rights to the Daiichi Sankyo compound three years ago in a deal worth up to $6.9 billion.